Author:
Whelan J. S.,Smith T. A.,Rohatiner A. Z. S.,Lister T. A.,Meuth M.
Publisher
Springer Berlin Heidelberg
Reference18 articles.
1. Carey RW (1970) Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine or daunomycin in acute myelocytic leukaemia. Proc AACR 11: 15
2. Crowther D, Baterman CJ, Vartan CP et al. (1970) Combination chemotherapy using Lasparaginase, daunorubicin, and cytosine arabinoside in adults with acute myeIogeneous leukaemia. Br Med J 4: 513–7
3. Rohatiner AZS, Lister TA (1990) The treatment of acute myelogenous leukaemia. in Leukaemia, Henderson ES and Lister TA, Editor. Saunders WB Co.: Philadelphia. p. 485–513
4. Bradley G, Jaranka PF, Ling V (1988) Mechanism of multidrug resistance. Biochim Biophys Acta 948: 87–128
5. Tattersall MH, Ganeshaguru K, Hoftbrand A V (1974) Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol 27: 39–46